Apod-deficient mice display an altered lipidomic profile with elevated plasma triglycerides and insulin, without changes in glucose homeostasis evaluated by glucose tolerance test [61]; whereas mice overexpressing human APOD develop insulin resistance and hepatic steatosis with aging, but not with obesity or inflammation [62,63]. The gene discussed is INS; the disease is obesity disorder.